A61K 49/0017
Fluorescence in vivo
Official title: {Fluorescence in vivo}
A61K49/0017 (Fluorescence in vivo) appears on 2,913 US grants and 4,816 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,913
- Published applications
- 4,816
- Assignees
- 1,767
- Inventors
- 8,969
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 7 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 8 | 0 |
| 1995 | 14 | 0 |
| 1996 | 13 | 0 |
| 1997 | 18 | 0 |
| 1998 | 31 | 0 |
| 1999 | 26 | 0 |
| 2000 | 24 | 0 |
| 2001 | 39 | 12 |
| 2002 | 30 | 45 |
| 2003 | 26 | 73 |
| 2004 | 21 | 78 |
| 2005 | 22 | 87 |
| 2006 | 23 | 75 |
| 2007 | 34 | 102 |
| 2008 | 45 | 132 |
| 2009 | 34 | 148 |
| 2010 | 39 | 159 |
| 2011 | 68 | 219 |
| 2012 | 90 | 180 |
| 2013 | 112 | 223 |
| 2014 | 162 | 263 |
| 2015 | 155 | 271 |
| 2016 | 178 | 283 |
| 2017 | 222 | 279 |
| 2018 | 169 | 293 |
| 2019 | 228 | 273 |
| 2020 | 229 | 326 |
| 2021 | 170 | 259 |
| 2022 | 142 | 236 |
| 2023 | 142 | 225 |
| 2024 | 146 | 241 |
| 2025 | 129 | 191 |
| 2026 | 86 | 143 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- Bimetallic fluorescent nanocomposites for cancer theranostics29 Sep 2026US 12,746,598 B2Council of Scientific and Industrial Research
- Methods and compositions for delivery of agents across the blood-brain barrier29 Sep 2026US 12,747,269 B2The Brigham and Women S Hospital, Inc.
- Antibodies targeting glioblastoma stem-like cells and methods of use thereof22 Sep 2026US 12,742,019 B2Wisconsin Alumni Research Foundation
- Probe directed to enzyme ALDH1A3 and use thereof in the diagnosis of glioblastoma15 Sep 2026US 12,734,254 B2Universita Degli Studi Del Piemonte Orientale “A. Avogadro”
- Fluorescein-labeled nerve targeting peptide formulations and related methods8 Oct 2026US 2026/0306676 A1Alume Biosciences, Inc.
- Method for detecting a gd2 positive cancer8 Oct 2026US 2026/0306677 A1Prinses Maxima Centrum Voor Kinderoncologie B.V.
- Voltage sensitive thiazolothiazole dyes and associated synthetic methods8 Oct 2026US 2026/0308176 A1
- Method for Medical Imaging1 Oct 2026US 2026/0294251 A1Integro Theranositcs, LLC
- Fluorescent sensors and methods of making and using1 Oct 2026US 2026/0295095 A1Howard Hughes Medical Institute
Most cited
By later US patents
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors891US 8,008,088 B2Masimo Laboratories, Inc. · 2011
- Systems and methods for in vitro and in vivo imaging of cells on a substrate841US 9,274,095 B2Doheny Eye Institute · 2016
- Non-invasive measurement of analytes836US 8,509,867 B2Cercacor Laboratories, Inc. · 2013
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors707US 8,029,765 B2Masimo Laboratories, Inc. · 2011